A composite MyD88/CD40 switch synergistically activates mouse and human dendritic cells for enhanced antitumor efficacyPriyadharshini Narayanan(Baylor College of Medicine), David M. Spencer(Baylor College of Medicine)Journal of Clinical InvestigationMarch 7, 201110.1172/jci44327Cited by 54SaveCiteExport RISWatch citationsRelated PapersMyD88/CD40 Genetic Adjuvant Function in Cutaneous Atypical Antigen-Presenting Cells Contributes to DNA Vaccine Immunogenicity|PLoS ONE|2016|5